Phase Holographic Imaging PHI AB (publ), a medical technology company, develops and markets non-invasive time-lapse imaging instruments in Sweden and internationally. The company’s products include HoloMonitor, a live cell imaging system; HoloMonitor app Suite for cell imaging software facilitates kinetic live cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonitor for single cell tracking, kinetic dose response and cell motility, cell morphology, wound healing, cell quality control, cell counter, and kinetic cell proliferation assay. It also provides HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to keep optics and interior of HoloMonitor free from condensation. Its products are used in cancer research, stem cells, drug discovery and development, single-cell analysis and tracking, cell counting, cell quality check, cell proliferation, cell morphology, cell migration, cell motility and migration, wound healing, and dose responses. Phase Holographic Imaging PHI AB (publ) was incorporated in 1997 and is headquartered in Lund, Sweden.
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Over the last 7 days, the market has dropped 1.1%, driven by a pullback of 1.7% in the Industrials sector. In the last 12 months the market has been flat overall. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›